
Synergistic activity of imatinib and AR-42 against chronic myeloid leukemia cells mainly through HDAC1 inhibition
Keywords: لوسمی میلوئید مزمن; Chronic myeloid leukemia; Combination therapy; Imatinib; AR-42; HDAC1;